SGLT-2 Inhibitors in Heart Failure: Putting the Evidence Into Practice

Published: 27 August 2021

Views:
6406
Likes:
4

Overview

Full programme

Views:
6406
Likes:
4

Overview

Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Prof Andrew Coats (Monash University, Australia and University of Warwick, UK) and Prof Giuseppe Rosano (St George's, University of London, UK) discuss the implications for treatment strategies.

This three-part series provides comprehensive update on some of the most important developments in HFrEF management including addressing key considerations of where SGLT-2 inhibitors fit into the new guidelines for HFrEF, when and how to initiate SGLT-2 inhibitors, and making evidence-based choices in the selection of SGLT-2 inhibitor.

This programme is supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

Recall the latest recommendations and levels of evidence supporting the use of SGLT-2 inhibitors in heart failure (HF)
Consider the impact of delaying the adoption of all guideline-directed foundational therapies in existing HF
Make an evidence-based choice when selecting an SGLT-2 inhibitor in HF

Target Audience

Heart failure specialists
Cardiologists
Referring physicians
Allied health professionals

Series overview

Part 1

Where Do SGLT-2 Inhibitors Fit Into the New Guidelines for HFrEF?

1 session

Where Do SGLT-2 Inhibitors Fit Into the New Guidelines?
Watch now

Part 2

When and How to Initiate SGLT-2 Inhibitors in HFrEF

1 session

When and How to Initiate SGLT-2 Inhibitors in HFrEF
Watch now

Part 3

Choosing an SGLT-2 Inhibitor – Making an Evidence-based Choice

1 session

Choosing an SGLT-2 Inhibitor – Making an Evidence-based Choice
Watch now

Faculty biographies

Andrew JS Coats
Giuseppe Rosano

Andrew JS Coats

Director of the Monash Warwick Alliance and Academic Vice-President

Prof Coats is Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. His research greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He has a vast experience in education and publishing.

Prof Coats attended Melbourne Grammar School and studied at Oxford and Cambridge. He has a higher doctorates from Oxford (DM) and Imperial (DSc.). He was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust. Prof Coats was appointed Dean of Medicine at the University of Sydney in 2002, and subsequently Deputy Vice-Chancellor. He was most recently CEO of the Norwich Research Park, the UK's oldest and largest research and innovation park.

His research interests are chronic heart failure, hypertension, and organizational behaviour. Prof…

View full profile

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London where he is also the director of MSc Heart Failure.

After obtaining his MD in Medicine and Surgery at the La Sapienza University of Rome, Prof Rosano obtained his specialisation in cardiology from the same University before attaining his PhD in Medical Sciences from Imperial College London. His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases.

View full profile